Dossier zur Nutzenbewertung gemäß § 35a SGB V
siRNA drug Leqvio (inclisiran) to lower cholesterol: Trends in Pharmacological Sciences
The novel siRNA inclisiran and population health management - Walker - 2023 - Prescriber - Wiley Online Library
Cureus | Can Clinicians Start Prescribing Inclisiran for Hypercholesterolemia Today? A Review of Clinical Studies for Internal Medicine Physicians and Endocrinologists | Article
A) Simplified overview of mechanism of action by Inclisiran.... | Download Scientific Diagram
Therapeutic siRNA: state of the art | Signal Transduction and Targeted Therapy
Frontiers | Non-antibody Approaches to Proprotein Convertase Subtilisin Kexin 9 Inhibition: siRNA, Antisense Oligonucleotides, Adnectins, Vaccination, and New Attempts at Small-Molecule Inhibitors Based on New Discoveries
Leqvio - 5333 - EPAR
Small interfering ribonucleic acid for cholesterol lowering – Inclisiran: Inclisiran for cholesterol lowering - ScienceDirect
Inclisiran - an overview | ScienceDirect Topics
Neue Therapieoptionen zur Lipidkontrolle // New therapy options for lipid control
Frontiers | PCSK9 Inhibition: Insights From Clinical Trials and Future Prospects
Advances in oligonucleotide drug delivery | Nature Reviews Drug Discovery
Donovan/Green
Pharmaceutics | Free Full-Text | Inclisiran—Safety and Effectiveness of Small Interfering RNA in Inhibition of PCSK-9
Small Interfering RNA Therapeutic Inclisiran: A New Approach to Targeting PCSK9 | SpringerLink
The chemical structure and phosphorothioate content of hydrophobically modified siRNAs impact extrahepatic distribution and effi
siRNA drug Leqvio (inclisiran) to lower cholesterol: Trends in Pharmacological Sciences
Trends in Pharmacological Sciences on Twitter: "drug Leqvio (inclisiran), that lowers cholesterol in patients with heterozygous familial hypercholesteremia and atherosclerotic cardiovascular disease (https://t.co/t3BJWjuwyT). The editorial in the May ...
A Highly Durable RNAi Therapeutic Inhibitor of PCSK9 | NEJM
Clinical potential of inclisiran for patients with a high risk of atherosclerotic cardiovascular disease | Cardiovascular Diabetology | Full Text
Clinical potential of inclisiran for patients with a high risk of atherosclerotic cardiovascular disease | Cardiovascular Diabetology | Full Text
![PDF] Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1f1a62bb4b78002fe02ac9051fa4b11c68450b83/9-Figure2-1.png "PDF] Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol | Semantic Scholar")